Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Universal Ibogaine Inc ( (TSE:IBO) ) has issued an announcement.
Universal Ibogaine Inc. has appointed Nia Killebrew and Tony Wagner as new members of its Board of Directors, effective August 28, 2025. This move comes ahead of the company’s Annual Meeting of Shareholders and is part of its ongoing efforts to strengthen its leadership as it advances its mission to revolutionize addiction treatment. The appointments are expected to bolster the company’s strategic direction as it prepares for a clinical trial in Canada and seeks to expand its treatment protocols globally.
More about Universal Ibogaine Inc
Universal Ibogaine Inc. is a life sciences company focused on transforming addiction treatment through medicalized ibogaine. The company is planning a Canadian clinical trial targeting opioid use disorder and aims to expand globally through future licensing agreements. Additionally, UI is developing a holistic addiction treatment protocol at its Kelburn Recovery Centre near Winnipeg, Manitoba.
Average Trading Volume: 312,542
Technical Sentiment Signal: Sell
Current Market Cap: C$4.12M
See more data about IBO stock on TipRanks’ Stock Analysis page.